Table 10.
Prevalence of MetS and its criteria in the study population [n (%)].
| Parameter | Psychiatric hospital patients, n | |||
|---|---|---|---|---|
| (1) Kemerovo, 94 | (2) Tomsk, 131 | (3) Omsk, 91 | p-value | |
| MetS prevalence | 19 (20.2%) | 48 (36.6%) | 17 (18.7%) | p1−2 = 0.008* |
| p1−3 = 0.793 | ||||
| p2−3 = 0.004* | ||||
| Waist circumference | 36 (38.3%) | 76 (58.0%) | 35 (38.5%) | p1−2 = 0.004* |
| p1−3 = 1.000 | ||||
| p2−3 = 0.006* | ||||
| Blood pressure | 19 (20.2%) | 36 (27.5%) | 25 (27.5%) | 0.398 |
| Fasting glucose | 18 (19.1%) | 19 (14.5%) | 9 (9.9%) | 0.203 |
| Triglyceride | 31 (33.0%) | 46 (35.1%) | 19 (20.9%) | 0.062 |
| HDL-C | 69 (73.4%) | 83 (63.4%) | 50 (54.9%) | p1−2 = 0.112 |
| p1−3 = 0.009* | ||||
| p2−3 = 0.208 | ||||
*
p < 0.05, statistically significant difference; these data were analyzed using the χ2 test. MetS, metabolic syndrome; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol.